阿奇霉素治疗沙眼衣原体感染后阴道菌群非最优
该队列纳入149例生殖道沙眼衣原体感染女性,基线后每3个月随访至治疗后9个月,分析阴道菌群组成与结构。诊断时菌群以惰性乳杆菌或加德纳菌等细菌性阴道病相关菌为主;阿奇霉素1g单剂治疗后惰性乳杆菌优势群落最常见,与惰性乳杆菌对该药相对耐药一致。惰性乳杆菌优势群落与沙眼衣原体感染风险升高相关,提示抗生素对菌群的扰动可能利于再感染。
要点
- 沙眼衣原体感染女性诊断时阴道菌群多为惰性乳杆菌或细菌性阴道病相关菌。
- 阿奇霉素1g单剂治疗后最常见惰性乳杆菌优势群落,与其相对耐药一致。
- 抗生素扰动菌群可能利于再感染,需保护并恢复最优阴道菌群。
核心结论
- 阿奇霉素治疗沙眼衣原体感染后阴道菌群常呈非最优状态,以惰性乳杆菌优势群落为主,可能利于再感染。
研究设计与样本
- 队列研究,纳入149例基线生殖道沙眼衣原体感染女性,治疗后每3个月随访共9个月,分析阴道菌群组成与结构。
主要发现
- 诊断时阴道菌群以惰性乳杆菌或包括加德纳菌在内的多种细菌性阴道病相关菌为主。
- 阿奇霉素1g单剂治疗后惰性乳杆菌优势群落最常见,与观察到的惰性乳杆菌对阿奇霉素相对耐药一致。
- 惰性乳杆菌优势群落与沙眼衣原体感染风险增加相关,提示抗生素对菌群的影响可能利于再感染。
临床怎么用
- 治疗沙眼衣原体感染时应考虑抗生素对阴道菌群的扰动效应,并关注保护和恢复最优阴道菌群的策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
We characterized the composition and structure of the vaginal microbiota in a cohort of 149 women with genital Chlamydia trachomatis infection at baseline who were followed quarterly for 9 months after antibiotic treatment. At time of diagnosis, the vaginal microbiota was dominated by Lactobacillus iners or a diverse array of bacterial vaginosis-associated bacteria including Gardnerella vaginalis. Interestingly, L. iners-dominated communities were most common after azithromycin treatment (1 g monodose), consistent with the observed relative resistance of L. iners to azithromycin. Lactobacillus iners-dominated communities have been associated with increased risk of C. trachomatis infection, suggesting that the impact of antibiotic treatment on the vaginal microbiota could favor reinfections. These results provide support for the dual need to account for the potential perturbing effect(s) of antibiotic treatment on the vaginal microbiota, and to develop strategies to protect and restore optimal vaginal microbiota.
引用
- Tamarelle J, Ma B, Gajer P, et al. Nonoptimal Vaginal Microbiota After Azithromycin Treatment for Chlamydia trachomatis Infection. J Infect Dis. 2020. PMID: 31573603. doi:10.1093/infdis/jiz499
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。